Global Strongyloidiasis Treatment Market, By Type (Acute Strongyloidiasis and Chronic Strongyloidiasis), Diagnosis Tests (Duodenal Aspiration Test, Sputum Culture Test, Stool Test, Complete Blood Count (CBC) Test, and Blood Antigen Test), Treatment Type (First Line Therapy And Second Line Therapy), Dugs Class (Antiparasitic Drugs and Others), End Users (Clinics, Hospitals, and Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028